ARDX Deadline Alert: SueWallSt Reminds Ardelyx, Inc. (ARDX) Investors of Securities Class Action Deadline on November 16, 2026
A securities class action is pending against Ardelyx on behalf of shareholders who purchased between January 13, 2025 and August 6, 2026; the lead plaintiff deadline is November 16, 2026. The complaint alleges Ardelyx reaffirmed a $1.75 billion combined peak sales framework for IBSRELA and XPHOZAH while payer prior-authorization and step-edit barriers allegedly slowed new-patient starts. The alleged corrective disclosure came on August 6, 2026, when Ardelyx cut FY2026 IBSRELA guidance and withdrew long-term XPHOZAH guidance; the stock fell about 18% the next day, from $4.87 to $4.00.
Key figures
- Stock decline
- $0.87 (from $4.87 to $4.00)
- Stock drop pct
- approximately 18%
- Class period end
- 2026-08-06
- Class period start
- 2025-01-13
- Lead plaintiff deadline
- 2026-11-16
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.